Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Significance of cycle 1 bone marrow biopsy in predicting outcomes and toxicities of venetoclax-based therapy for myeloid malignancies.
Journal: Leukemia & lymphoma
Published: December 27, 2024
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 16, 2024
Immune Checkpoint Inhibitor Therapy and Associations with Clonal Hematopoiesis.
Journal: International journal of molecular sciences
Published: September 06, 2024
Updates in novel immunotherapeutic strategies for relapsed/refractory AML.
Journal: Frontiers in oncology
Published: January 23, 2024
Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia.
Journal: Blood cancer journal
Published: July 08, 2023
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 08, 2023
FLT3-mutated acute myeloid leukaemia: a new opportunity.
Journal: Lancet (London, England)
Published: March 02, 2023
Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia.
Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia.
Journal: Frontiers in oncology
Published: December 01, 2021
Targeting acute myeloid leukemia through multimodal immunotherapeutic approaches.
Journal: Leukemia & lymphoma
Published: November 25, 2021
Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 22, 2021
Last Updated: 09/26/2026